Mass Tort brief
Defense Wins and Evidentiary Battles Reshape High-Stakes Multidistrict Litigation
From infant formula bellwethers to GLP-1 science hearings, judges and juries are setting strict procedural parameters across major federal injury dockets.
Mass Tort
Mead Johnson's federal bellwether victory sets defense momentum across 800 infant formula suits — proving juries can accept manufacturer warning labels over emotional injury claims.
BackgroundOver 800 lawsuits are consolidated in federal multidistrict litigation alleging infant formula makers failed to warn that cow's milk products increase intestinal disease risks in premature infants. Previous state court trials yielded mixed results, including major damage awards against formula producers.
- Federal jurors found Mead Johnson adequately warned healthcare providers about potential NEC risks associated with premature infant formula, defeating claims of failure to warn.
- US Senior District Judge Rebecca Pallmeyer presided over the federal trial following previous summary judgment orders that dismissed co-defendant Abbott Laboratories from the suit.
- The defense victory establishes key federal trial precedent as plaintiffs pivot strategy toward remaining state court dockets in Illinois and Missouri.
Mass Tort
Judge Marston's Daubert ruling will decide the fate of 4,000 Ozempic lawsuits — determining whether plaintiffs have sufficient scientific proof to reach bellwether juries.
BackgroundMultidistrict litigation consolidates thousands of federal injury claims to resolve overarching legal and scientific questions before trial. Rule 702 Daubert hearings act as a judicial gatekeeper to filter out unreliable expert medical testimony before juries evaluate damages.
- Defense attorneys for Novo Nordisk and Eli Lilly are attempting to disqualify 8 core medical experts presented by plaintiffs to prove gastroparesis causation.
- Judge Marston will decide whether existing clinical studies sufficiently prove a causal link between GLP-1 receptor agonists and permanent stomach paralysis.
- A separate federal judicial panel oversees 200 parallel lawsuits alleging vision loss and non-arteritic anterior ischemic optic neuropathy tied to GLP-1 use.
Mass Tort
Judicial scrutiny of Paraquat opt-outs threatens Syngenta's global settlement deal — revealing growing court friction with mass tort law firms over client advisory standards.
BackgroundThe Paraquat multidistrict litigation includes over 6,600 federal lawsuits alleging long-term exposure to the chemical herbicide causes Parkinson's disease. Global mass tort settlements typically require high plaintiff participation thresholds to unlock defense funding contributions.
- Judge Rosenstengel scheduled mandatory individual conferences with a Special Master to review plaintiff settlement rejections and ensure claimants understand agreement terms.
- The court raised concerns over whether mass tort law firms adequately informed non-settling clients regarding settlement matrix calculations and recovery timelines.
- Over 6,600 federal actions remain active against Syngenta and Chevron, alongside 2,000 parallel state court cases consolidated in Philadelphia.
Mass Tort
The claim deadline closes Disney's $50M antitrust suit — resolving allegations that sports broadcast leverage forced competing live TV streaming services to hike subscription fees.
BackgroundAntitrust class actions allow affected consumers to recover financial damages when anti-competitive corporate deals artificially inflate market prices. Video distribution contracts frequently contain restrictive carriage provisions governing base package channel pricing across competing platforms.
- Eligible YouTube TV and DirecTV Stream subscribers submitted online claim forms for direct financial payouts prior to the midnight filing deadline.
- The lawsuit alleged Disney used essential ESPN carriage agreements to force competing live streaming providers to raise consumer subscription prices from 2019 through 2026.
- US District Judge Edward Davila will preside over final settlement approval hearings in early 2027 to finalize payout distributions.
Mass Tort
Mass Tort
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
